Catalyst Pharmaceuticals (CPRX) Assets Average (2011 - 2026)

Catalyst Pharmaceuticals' Assets Average history runs 16 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• Quarterly Assets Average rose 27.91% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 27.91% YoY) and the FY2025 annual result came in at $977.7 million, up 47.96% from the prior year.
• Assets Average was $1.1 billion for Q1 2026 at Catalyst Pharmaceuticals, up from $1.1 billion in the prior quarter.
• Across five years, Assets Average topped out at $1.1 billion in Q1 2026 and bottomed at $242.4 million in Q1 2022.
• A 5-year average of $627.2 million and a median of $558.4 million in 2024 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average rose 24.43% — and 2024, when it surged 83.79%.
• Catalyst Pharmaceuticals' Assets Average stood at $354.4 million in 2022, then climbed by 24.63% to $441.7 million in 2023, then surged by 83.79% to $811.7 million in 2024, then jumped by 32.78% to $1.1 billion in 2025, then grew by 4.45% to $1.1 billion in 2026.
• Business Quant data shows CPRX's Assets Average at $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.0 billion in Q3 2025.